Female Mitochondria
The Power Source.
And Why It Is Female.
Every cell in your body contains hundreds of mitochondria. They produce the energy that powers every heartbeat, every thought, every movement. They are maternally inherited. They make all your sex hormones. They have estrogen receptors inside them. They are not incidental to female biology. They are central to it.
There is a chain. Thalassemia reduces haemoglobin. Less haemoglobin means less oxygen delivered to cells. That oxygen enters the mitochondria — the structures inside every cell that use it to generate energy. Without adequate oxygen, the chain backs up. Electrons accumulate. Reactive oxygen species increase. ATP production falls. And everything downstream of that — which is everything — runs slower, harder, at higher cost, and without an explanation that anyone thought to provide.
This is what fatigue is, at the cellular level. Not tiredness in the general sense. The specific, measurable insufficiency of ATP production in cells that are trying to do more than their energy supply can support. I did not understand this for nineteen years. Partly because nobody had diagnosed what was causing the oxygen deficiency. But also because nobody had framed the question that way — fatigue as a cellular energy problem, not a psychological one, not a lifestyle one, not the inevitable cost of being the kind of person who feels things too much.
This post is about mitochondria. What they are, what they do beyond making energy, and why their relationship with the female body is more specific and more clinically significant than any biology textbook has bothered to explain. There are three things about mitochondria that most people — including most doctors — do not know. All three have direct implications for the health of every woman reading this.
Before the science: here is what one actually looks like.
Inside the Mitochondrion
Every part of it does something — and several of those parts interact directly with the female hormonal system. Tap anything.
Schematic cross-section · Not to scale · nammu.academy
Most people know mitochondria make energy. What most people do not know is that they also make all your sex hormones, contain their own genome that was inherited entirely from your mother, have estrogen receptors sitting inside the matrix itself, and are structurally and functionally different in the female body in ways that have direct clinical consequences. The textbook version stops at ATP. The science does not.
Mitochondria produce ATP — adenosine triphosphate — through oxidative phosphorylation: a cascade of five protein complexes in the inner membrane through which electrons are passed, protons are pumped, and the resulting gradient drives a molecular turbine spinning at 150 revolutions per second. The raw materials are oxygen, glucose-derived compounds, and dietary nutrients. At rest, your body produces roughly its own weight in ATP every day. The moment the chain is disrupted — by insufficient oxygen, by iron deficiency depleting the iron-sulphur clusters in Complexes I, II, and III, by thyroid hormone deficiency slowing Complex IV — ATP output falls. And you feel it. Not as tiredness. As a cellular insufficiency that sleep does not fix and rest does not resolve, because the problem is not fatigue — it is energy production.
Female mitochondria have higher antioxidant capacity and better respiratory efficiency — largely through estrogen. A comprehensive review in Redox Biology confirmed that in most tissues studied, female mitochondria show upregulated antioxidant enzyme expression, higher electron transport chain activity, greater ATP production, and lower reactive oxygen species generation than male mitochondria. These differences are substantially driven by estrogen: estrogen receptor beta (ERβ) is found inside the mitochondrial matrix, where it interacts directly with mitochondrial DNA and influences bioenergetic function at the genetic level. Estrogen upregulates PGC-1α — the master transcription factor for mitochondrial biogenesis — and enhances antioxidant enzyme expression. Female rodents have higher electron transport chain capacity in the brain and enhanced oxidative stress protection in skeletal muscle. The female mitochondrial advantage is real, measurable, and estrogen-dependent. Which means it is also lost at menopause. [1]
The first step of every sex hormone is made inside the mitochondria. A 2023 meta-analysis in PNAS documented three structural links between mitochondria and biological sex. The first: all mammalian mitochondria are maternally inherited — passed exclusively through the egg. The sperm's mitochondria are tagged for destruction immediately after fertilisation. The second: the rate-limiting first step of all steroid hormone synthesis — the conversion of cholesterol to pregnenolone by the enzyme CYP11A1 — takes place in the mitochondrial matrix. Every estrogen molecule your ovaries have ever made began here. Every molecule of progesterone, cortisol, and testosterone started in this same compartment. Without functional mitochondria, sex hormone synthesis cannot begin. The third: ERβ and the androgen receptor both translocate into the mitochondrial matrix, where they interact with mitochondrial DNA directly. [2]
Mitochondrial dysfunction is a central mechanism in ME/CFS — which affects women three times more than men. A 2025 review by NIH researchers published in Physiology documented the mitochondrial mechanisms underlying ME/CFS and Long COVID. The review identified a specific pathway: ER stress causes WASF3 protein to accumulate at the contact points between the endoplasmic reticulum and mitochondria, where it disrupts the assembly of respiratory complexes and shuts down oxidative phosphorylation. The cell shifts to glycolysis — a far less efficient energy pathway. The result is the defining ME/CFS experience: post-exertional malaise, a worsening of symptoms after activity that reflects what happens when cells are forced to function on inadequate ATP. ME/CFS affects approximately 1% of the US population. Women are affected at three times the rate of men. This is not unexplained. It is mitochondrial. [3]
Iron deficiency impairs the electron transport chain directly — before haemoglobin falls. Complexes I, II, and III of the electron transport chain depend on iron-sulphur clusters embedded in their protein structures. Without adequate iron, these clusters cannot be assembled, and the complexes are structurally compromised. ATP output falls at the level of the machinery itself, independently of oxygen delivery. This is why iron deficiency causes fatigue before anaemia: the mitochondria are already running without a structural component they cannot substitute. And it creates a specific compounding vulnerability — a woman who is iron deficient is simultaneously dealing with impaired oxygen transport and impaired capacity to use the oxygen that does arrive. The two deficiencies amplify each other at the cellular energy level. [4]
Estrogen withdrawal at menopause directly impairs mitochondrial structure and function. A review in Frontiers in Endocrinology documented the specific pathways by which estrogen regulates mitochondrial dynamics — the continuous cycle of fusion and fission that maintains mitochondrial quality. Estrogen promotes fusion (keeping mitochondria healthy and interconnected) and regulates fission (preventing fragmentation). When estrogen withdraws at menopause, fragmentation increases, ROS production rises, and ATP output falls across multiple tissues simultaneously. The brain fog, fatigue, and cognitive changes of menopause are substantially consistent with impaired mitochondrial function in neurons. The perimenopause transition is not only a hormonal transition. It is a mitochondrial one. [5]
The first step of making estrogen happens inside the mitochondria. Estrogen then re-enters the mitochondria through its own receptor to regulate how efficiently they produce energy. The relationship is circular, ancient, and built into the architecture of the cell. The mitochondria and the female hormonal system did not evolve alongside each other. They evolved together.
The Electron Transport Chain
Click each complex to see what it does — and where the female body has specific vulnerability
The relationship between mitochondria and the female body is not incidental. It is structural. Built into three specific biological facts that most people — including most doctors — have never had reason to consider together. Each of them has clinical implications on its own. Together, they are one of the most underappreciated frameworks in women's health biology. And they are not new discoveries. They have simply not been communicated.
Three Reasons the Mitochondria Are Female
Click each to explore the mechanism and what it actually means
🔵 = mitochondria passed. Paternal mitochondria are destroyed after fertilisation.
Iron deficiency impairs the electron transport chain through iron-sulphur cluster depletion — before haemoglobin falls, before any standard blood test flags a problem. Women who are iron deficient are running compromised mitochondria. Their cells are generating less ATP from every molecule of oxygen that arrives. This is why iron deficiency fatigue presents before anaemia, why it is disproportionate to what a haemoglobin result would suggest, and why "your haemoglobin is fine" is not a complete answer to the cellular energy question. The standard test is measuring the wrong thing.
T3 — active thyroid hormone — directly upregulates the expression of Complex IV subunits and mitochondrial biogenesis genes. In hypothyroidism, which affects women at 200 times the male rate, Complex IV activity is reduced. The electron transport chain slows. ATP output falls across every tissue simultaneously — heart, brain, muscle, gut, skin. The fatigue of hypothyroidism is not vague. It is the experience of cells generating less energy than they need, all day, because the hormone that instructs them to run efficiently has withdrawn. The mitochondria are the mechanism. The thyroid is the governor.
Chronic cortisol elevation suppresses PGC-1α — the same transcription factor that estrogen upregulates. Cortisol and estrogen have directly opposing effects on mitochondrial maintenance. Estrogen builds. Cortisol dismantles. In women under chronic stress, this means the mitochondrial quality that estrogen is working to maintain is being simultaneously degraded by cortisol. The fatigue that comes with chronic stress is not psychological. It is a reduction in mitochondrial biogenesis. The power source is being run down faster than it can be rebuilt.
Mitochondrial quality control — identifying and removing damaged mitochondria, replacing them with new ones — is concentrated in sleep, particularly in slow-wave sleep. BDNF, which supports mitochondrial biogenesis in neurons, peaks in slow-wave sleep. The luteal phase disrupts sleep architecture through progesterone's thermogenic effect, reducing the depth and duration of the window in which mitochondrial repair is prioritised. The fatigue of luteal-phase sleep disruption accumulates. It is not just tiredness. It is interrupted maintenance on the cellular power grid.
Every mitochondrion in your body came from your mother. She got hers from her mother. The power source that runs every cell — that makes every heartbeat possible, that produces the first molecule of every sex hormone, that generates the ATP your neurons use to read this right now — has been passed from woman to woman for 150,000 years. Not incidentally. By evolutionary design. The mitochondrial genome is, in a specific and documented sense, optimised for the female body. That optimisation is real, measurable, and estrogen-dependent.
For nineteen years, my mitochondria were running under constraint. Not because they were defective. Because they were oxygen-deprived by a condition nobody had thought to tell me I had. Every cell was doing what cells do: adapting, compensating, producing what it could with what it had. The sodium-potassium pumps were still running. The action potentials were still firing. The electron transport chain was still turning, just not at full efficiency. But adaptation is not the same as adequacy. When the oxygen is chronically low and the iron stores are competing for a substrate that is also low and the sleep is disrupted by the physiological cost of the whole thing — the mitochondria fall behind. The ATP deficit accumulates. The fatigue is not a perception. It is a measurement.
What I want for every woman reading this is the same thing I eventually got: a frame. Not the frame that says your fatigue is a lifestyle problem or a mindset problem or a problem with how you are handling the demands of your life. The frame that says your body is a system, your cells have a mechanism, and when that mechanism is under constraint — from low iron, from low thyroid hormone, from undiagnosed thalassemia, from chronic cortisol, from the mitochondrial transition of perimenopause — the fatigue is real because the energy deficit is real. The physics was working correctly. The chemistry was following its rules. What was missing was not effort. What was missing was oxygen, and iron, and the diagnosis.
Your power source is ancient and extraordinary. Love, Nina ❤References
- Gaignard, P., et al. (2017). Role of sex hormones on brain mitochondrial function, with special reference to aging and neurodegenerative diseases. Frontiers in Aging Neuroscience, 9, 406. https://doi.org/10.3389/fnagi.2017.00406
- Trumpff, C., et al. (2023). Human studies of mitochondrial biology demonstrate an overall lack of binary sex differences: A multivariate meta-analysis. PNAS, 120(6). https://doi.org/10.1073/pnas.2216697120
- Syed, A. M., et al. (2025). Mitochondrial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. Physiology, 40(4). https://doi.org/10.1152/physiol.00056.2024
- Hoes, M. F., et al. (2018). Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. European Journal of Heart Failure, 20(5), 910–919. https://doi.org/10.1002/ejhf.1154
- Ventura-Clapier, R., et al. (2020). Estrogens, estrogen receptors effects on cardiac and skeletal muscle mitochondrial bioenergetics. Frontiers in Endocrinology, 10, 557. https://doi.org/10.3389/fendo.2019.00557